Cellular Biomedicine Group Company
CBMG is a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancers and stem cell therapies.
Technology:
CAR-T
Industry:
Cell Therapy, Delisted
Headquarters:
Palo Alto, California, United States
Founded Date:
2009-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
7
Total Funding:
203643001
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021-09-28
Last Funding Type:
Series A
Register and Claim Ownership